Senju Pharmaceutical Co., Ltd.;Kyoto Prefectural Public University Corporation;The Doshisha
发明人:
KOIZUMI, Noriko,OKUMURA, Naoki,KINOSHITA, Shigeru
申请号：
EP15854105
公开号：
EP3213761A4
申请日:
2015.10.30
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides a technique for treating retinal epithelium and/or nerves. More specifically, the present invention is an agent for the treatment or prevention of retinal disease or the like and/or a disease, disorder, or ophthalmological state of the nerves, the agent including at least one factor selected from the group consisting of laminin and fragments thereof, wherein the problem is solved by also providing a technique characterized in that this agent is administered together with retinal pigment epithelial cells and/or nerve cells. Specifically, the present invention can include laminin 411 (±4²1³1), laminin 511 (±5²1³1), laminin 521 (±5²2³1), or fragments of these.
